With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.170911-92-9,tert-Butyl 4-(4-aminophenyl)piperazine-1-carboxylate,as a common compound, the synthetic route is as follows.
A mixture of 8-cyclopentyl-2-methanesulfinyl-6-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-8H-pyrido[2,3-d]pyrimidin-7-one (185 mg, 0.495 mmol) and 4-(4-amino-phenyl)-piperazine-1-carboxylic acid tert-butyl ester (247 mg, 0.892 mmol, 1.8 eq) were dissolved in DMSO (2.5 mL) and heated at 80 C. for 2 days. Succinic anhydride (70 mg) was added to react with the excess aniline and the mixture was heated at 80 C. for 3 h. The reaction mixture was partitioned between ethyl acetate and H2O. The organic layer was washed with saturated NaHCO3 (2×), H2O and brine, dried over Na2SO4 and concentrated to give an orange foam. Purification by liquid chromatography (2-4% MeOH/CH2Cl2) gave 4-{4-[8-cyclopentyl-6-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino]-phenyl}-piperazine-1-carboxylic acid tert-butyl ester as a yellow foam (202 mg, 0.344 mmol, 70%). The structure was confirmed by NMR and mass spectrometry. MS: APCl: M+1: 587.1 (Exact Mass: 586.30)., 170911-92-9
The synthetic route of 170911-92-9 has been constantly updated, and we look forward to future research findings.
Reference：
Patent; PFIZER INC; US2006/142312; (2006); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics